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The HIV-1 Vpu protein has long been known to enhance
the release of virions from infected cells and to induce
proteasomal degradation of the CD4 receptor. While the
mechanism of CD4 degradation has been reasonably well
explored, our mechanistic understanding of how Vpu
facilitates virus release has remained vague. A break-
through came with the recent identification of Bst-2 (also
referred to as CD317 or tetherin). Bst-2 is a host factor
whose expression is associated with the inhibition of HIV-
1 virus release. Interestingly, Vpu is not the only viral
accessory protein with the ability to overcome the inhibi-
tory effect of Bst-2. Indeed, some HIV-2 isolates, although
lacking a vpu gene, have been known to encode a Vpu-like
activity in their Env glycoprotein and were now shown to
antagonize Bst-2. Very recently, several SIV Nef isolates
have also been associated with enhanced virus release
through inhibition of Bst-2 function. Thus, there appear
to be at least three retroviral proteins targeting Bst-2. Inter-
estingly, these are the same three viral proteins that can
target CD4. We have started a functional analysis to
understand at what level HIV-1 Vpu and HIV-2 Env pro-
teins interfere with Bst-2 function to determine if the
mechanisms for targeting CD4 and Bst-2 are the same or
not. Consistent with published reports we find that Vpu
can induce surface down modulation of Bst-2 and cause
degradation of Bst-2. However, Vpu can also facilitate
virus release in the absence of detectable Bst-2 surface
down modulation and degradation and in that respect
resembles the HIV-2 Env protein. Possible mechanisms of
Bst-2 inhibition by HIV-1 Vpu and HIV-2 Env will be dis-
cussed.
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